Home › Markets › Health Care › NMAD

Nomad Power Solutions Inc. (NMAD)

NMAD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$4.28
+2.64% on the day
Market cap
$68.9M
Micro cap
Revenue
No annual revenue filed since the period ending 2015-12-31
Net income
No annual revenue filed since the period ending 2015-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerNMAD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001335105
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2015-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-06-04
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-10-06
Latest proxyDEF 14A2026-07-27

Source: SEC EDGAR submissions feed, 527 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CINGCingulate Inc.$4.72-2.48%$68.6M
HYFTMindWalk Holdings Corp.$1.48+5.71%$69.7M
ZYBTZhengye Biotechnology Holding Limited$1.48-12.43%$70.1M
OSTXOS Therapies Incorporated$1.45-7.05%$67.4M
SPROSpero Therapeutics Inc.$1.15-2.54%$67.0M
MAIAMAIA Biotechnology Inc.$1.16-1.70%$71.6M
XBITXBiotech Inc.$2.16-5.68%$65.9M
RNTXRein Therapeutics Inc.$0.7546-3.86%$65.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier